A First-in-Human Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Novel Anti-Interleukin 1 Biologic Agent, Rph-104, in Healthy Subjects
Makaleler > Özet · 2017
Yazarlar: Ahmet Gül, Sibel Ulker, Recep Selim Senturk, Ugur Onsel Turk, Cemil GÜRGÜN, Yan Lavrovsky, Mikhail Samsonov, Sebnem Ozen, Serdar Altinel
ARTHRITIS & RHEUMATOLOGY, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2017, cilt 69